Eva Budinská
Eva Budinská
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα recetox.muni.cz
ΤίτλοςΠαρατίθεται απόΈτος
Patient-derived xenograft models: an emerging platform for translational cancer research
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
6862014
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
E Missiaglia, B Jacobs, G D'ario, AF Di Narzo, C Soneson, E Budinska, ...
Annals of oncology 25 (10), 1995-2001, 2014
3042014
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
E Budinska, V Popovici, S Tejpar, G D'Ario, N Lapique, KO Sikora, ...
The Journal of pathology 231 (1), 63-76, 2013
2842013
Interrogating open issues in cancer precision medicine with patient-derived xenografts
AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...
Nature Reviews Cancer 17 (4), 254, 2017
2202017
Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer
V Popovici, E Budinska, S Tejpar, S Weinrich, H Estrella, G Hodgson, ...
J Clin Oncol 30 (12), 1288-1295, 2012
1832012
Bullous pemphigoid and internal diseases–A case-control study
H Jedlickova, M Hlubinka, T Pavlik, V Semradova, E Budinska, Z Vlasin
European Journal of Dermatology 20 (1), 96-101, 2010
962010
A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations
T Xie, G d’Ario, JR Lamb, E Martin, K Wang, S Tejpar, M Delorenzi, ...
PloS one 7 (7), e42001, 2012
692012
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
ER Zanella, F Galimi, F Sassi, G Migliardi, F Cottino, SM Leto, B Lupo, ...
Science translational medicine 7 (272), 272ra12-272ra12, 2015
662015
Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014; 4: 998–1013. doi: 10.1158/2159-8290
M Hidalgo, F Amant, AV Biankin, E Budinska, AT Byrne, C Caldas, ...
CD-14-0001.[PMC free article][PubMed][Cross Ref], 0
56
aro mutations in Salmonella enterica cause defects in cell wall and outer membrane integrity
A Sebkova, D Karasova, M Crhanova, E Budinska, I Rychlik
Journal of bacteriology 190 (9), 3155-3160, 2008
482008
Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to …
K Brozkova, E Budinska, P Bouchal, L Hernychova, D Knoflickova, D Valik, ...
Breast Cancer Research 10 (3), R48, 2008
442008
67Copper-2-iminothiolane-6-[p-(bromoacetamido) benzyl]-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma
RT O'Donnell, GL DeNardo, DL Kukis, KR Lamborn, S Shen, A Yuan, ...
Clinical cancer research 5 (10), 3330s-3336s, 1999
431999
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
V Popovici, E Budinska, FT Bosman, S Tejpar, AD Roth, M Delorenzi
BMC cancer 13 (1), 439, 2013
422013
Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization
V Vranová, E NeCesalová, P Kuglík, P Cejpek, M PeSáková, E Budínská, ...
Oncology reports 17 (2), 457-464, 2007
412007
A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome
A Vasikova, M Belickova, E Budinska, J Cermak
Leukemia research 34 (12), 1566-1572, 2010
372010
Dirigent proteins in plants: modulating cell wall metabolism during abiotic and biotic stress exposure
C Paniagua, A Bilkova, P Jackson, S Dabravolski, W Riber, V Didi, ...
Journal of experimental botany 68 (13), 3287-3301, 2017
352017
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
NF Jensen, J Stenvang, MK Beck, B Hanáková, KC Belling, KN Do, B Viuff, ...
Molecular oncology 9 (6), 1169-1185, 2015
352015
Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014; 4 (9): 998–1013. doi: 10.1158/2159-8290
M Hidalgo, F Amant, AV Biankin, E Budinska, AT Byrne, C Caldas, ...
CD-14-0001.[PMC free article][PubMed][Cross Ref], 2012
352012
Unraveling an FNR based regulatory circuit in Paracoccus denitrificans using a proteomics-based approach
P Bouchal, I Struhárová, E Budinská, O Šedo, T Vyhlídalová, Z Zdráhal, ...
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1804 (6), 1350-1358, 2010
352010
Joint segmentation of multivariate Gaussian processes using mixed linear models
F Picard, É Lebarbier, E Budinská, S Robin
Computational Statistics & Data Analysis 55 (2), 1160-1170, 2011
342011
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20